Yanling Yin

Harbin Medical University — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

12h-index562citations40works2.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer-related molecular mechanisms research(19), RNA modifications and cancer(11), Circular RNAs in diseases(10), Cancer Immunotherapy and Biomarkers(8), Ferroptosis and cancer prognosis(7)

Publications40 total

16eP Efficacy and safety of bevacizumab biosimilar in the treatment of brain metastases from breast cancer: A prospective, single-arm, multicentre, real-world study
ESMO Open·2025Open Access
An Approach for Differential Diagnosis of Breast Tumors by <scp>ctDNA</scp> Methylation Sequencing
Cancer Medicine·2025· 1 citedOpen Access
The Mechanism of Action of the Active Ingredients of Coptidis rhizoma against Porcine Epidemic Diarrhea Was Investigated Using Network Pharmacology and Molecular Docking Technology
Viruses·2024· 7 citedOpen Access
Circular RNA ciRS-7 affects the propagation of Cryptosporidium parvum in HCT-8 cells via regulating miR-135a-5p/stat1 axis
Acta Tropica·2023· 5 cited
Supplementary Figures and Legends from Long Noncoding RNAs Control the Modulation of Immune Checkpoint Molecules in Cancer
2023Open Access
Supplementary Table S2 from Long Noncoding RNAs Control the Modulation of Immune Checkpoint Molecules in Cancer
2023Open Access
Supplementary Table S3 from Long Noncoding RNAs Control the Modulation of Immune Checkpoint Molecules in Cancer
2023Open Access
Supplementary Table S4 from Long Noncoding RNAs Control the Modulation of Immune Checkpoint Molecules in Cancer
2023Open Access
Data from Long Noncoding RNAs Control the Modulation of Immune Checkpoint Molecules in Cancer
2023Open Access
Supplementary Table S1 from Long Noncoding RNAs Control the Modulation of Immune Checkpoint Molecules in Cancer
2023Open Access
Data from Long Noncoding RNAs Control the Modulation of Immune Checkpoint Molecules in Cancer
2023Open Access
Supplementary Table S2 from Long Noncoding RNAs Control the Modulation of Immune Checkpoint Molecules in Cancer
2023Open Access
Supplementary Table S3 from Long Noncoding RNAs Control the Modulation of Immune Checkpoint Molecules in Cancer
2023Open Access
Supplementary Table S4 from Long Noncoding RNAs Control the Modulation of Immune Checkpoint Molecules in Cancer
2023Open Access
Supplementary Table S1 from Long Noncoding RNAs Control the Modulation of Immune Checkpoint Molecules in Cancer
2023Open Access
Supplementary Figures and Legends from Long Noncoding RNAs Control the Modulation of Immune Checkpoint Molecules in Cancer
2023Open Access
Characterization of CpCaM, a protein potentially involved in the growth of Cryptosporidium parvum
Parasitology Research·2023
Abstract P1-05-11: Improving the Performance of Early Breast Cancer Diagnosis by a Model Combining Breast Ultrasound with Methylation Markers in Non-Invasive Circulating Tumor DNA
Cancer Research·2023
Abstract P1-05-27: Liquid Biopsy for HER2 Status Assessment in Breast Cancer Using Surrogate DNA Methylation Markers
Cancer Research·2023· 1 cited
LncRNA TINCR impairs the efficacy of immunotherapy against breast cancer by recruiting DNMT1 and downregulating MiR-199a-5p via the STAT1–TINCR-USP20-PD-L1 axis
Cell Death and Disease·2023· 53 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Da Pang(23), Qin Wang(18), Yujuan Kang(18), Jiena Liu(17), Siwei Li(15), Meiying Shen(15), Shiyao Sui(14), Lei Liu(12), Shouping Xu(12), Wei Zheng(12), Hao Wu(11), Shouping Xu(10), Guang‐Hui Zhao(7), Qian Yao(7), Jun-Ke Song(7), Xianyu Zhang(5), Ting-Li Liu(5), Xin Yang(5), Shipeng Ning(4), Jian‐Bing Fan(4)